Countries citing papers authored by Mohammad Ghannadi‐Maragheh
Since
Specialization
Citations
This map shows the geographic impact of Mohammad Ghannadi‐Maragheh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Ghannadi‐Maragheh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Ghannadi‐Maragheh more than expected).
Fields of papers citing papers by Mohammad Ghannadi‐Maragheh
This network shows the impact of papers produced by Mohammad Ghannadi‐Maragheh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Ghannadi‐Maragheh. The network helps show where Mohammad Ghannadi‐Maragheh may publish in the future.
Co-authorship network of co-authors of Mohammad Ghannadi‐Maragheh
This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Ghannadi‐Maragheh.
A scholar is included among the top collaborators of Mohammad Ghannadi‐Maragheh based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Mohammad Ghannadi‐Maragheh. Mohammad Ghannadi‐Maragheh is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Yousefnia, Hassan, Ahmad Bitarafan‐Rajabi, Ali Bahrami‐Samani, et al.. (2016). Preclinical studies of 166Ho-chitosan for treatment of hepatocellular carcinoma. 24(1). 59–64.2 indexed citations
7.
Yousefnia, Hassan, Amir Reza Jalilian, F. Abbasi Davani, et al.. (2014). Preparation and quality control of 177Lu-chitosan for radiosynovectomy. 22(1). 1–6.3 indexed citations
8.
Moghaddam, B., et al.. (2013). Radiosynthesis of 191Os-2-acetylpyridine thiosemicarbazone complex, as an in vivo therapeutic radionuclide generator. 21(2). 53–59.3 indexed citations
9.
Moghaddam, B., et al.. (2012). Preparation and quality control of scandium-46 bleomycin as a possible therapeutic agent. 20(1). 19–24.8 indexed citations
10.
Shirvani‐Arani, Simindokht, et al.. (2012). PREPARATION AND QUALITY CONTROL OF 153SM-[TRIS (1, 10-PHENANTHROLINE) SAMARIUM (III)] COMPLEX. Iranian Journal of radiation research. 10(1). 59–62.2 indexed citations
11.
Ghannadi‐Maragheh, Mohammad, et al.. (2012). Production, Radiolabeling and Biodistribution Studies of 175Yb-DOTMP as Bone Pain Palliation. Iranian journal of pharmaceutical sciences. 8(2). 135–141.7 indexed citations
12.
Jalilian, Amir Reza, et al.. (2011). 放射免疫治療のための 166 Ho-DTPA-坑CD20の調製と品質管理. Radiochimica Acta. 99(4). 237–242.4 indexed citations
Bahrami‐Samani, Ali, et al.. (2009). PRODUCTION, QUALITY CONTROL AND BIOLOGICAL EVALUATION OF 153SM-EDTMP IN WILD-TYPE RODENTS. 17(2). 12–19.18 indexed citations
16.
Bahrami‐Samani, Ali, et al.. (2009). Development of 153 Sm-DTPA-rituximab for radioimmunotherapy. Nukleonika. 271–277.7 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.